Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
43
BKKT Quote, Financials, Valuation and Earnings
Last price:
$9.25
Seasonality move
:
18.76%
Day range:
$9.08 - $9.65
52-week range:
$5.57 - $37.21
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.02x
P/B ratio:
1.84x
Volume:
194.1K
Avg. volume:
437.4K
1-year change:
-4.32%
Market cap:
$62.3M
Revenue:
$3.5B
EPS (TTM):
-$7.93
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Bakkt Holdings has 36.41% upside to fair value with a price target of -- per share.
BKKT vs. S&P 500
-
Over the past 5 trading days, Bakkt Holdings has overperformed the S&P 500 by 5.26% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Bakkt Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bakkt Holdings has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Bakkt Holdings reported revenues of $1.8B.
Earnings Growth
-
Bakkt Holdings has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Bakkt Holdings reported earnings per share of -$2.95.
Enterprise value:
52.2M
EV / Invested capital:
--
Price / LTM sales:
0.02x
EV / EBIT:
--
EV / Revenue:
0.01x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-2.15x
Price / Operating cash flow:
1.39x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$87M
Return On Assets:
-5.14%
Net Income Margin (TTM):
-1.34%
Return On Equity:
-43.69%
Return On Invested Capital:
-43.69%
Operating Margin:
-0.61%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $55.7M | $780.1M | $3.5B | $214.5M | $1.8B | |
| Gross Profit | -- | $61.6M | $87M | $17.6M | $30.6M | |
| Operating Income | -$177.3M | -$128.2M | -$83.7M | -$23.7M | -$10.9M | |
| EBITDA | -$152M | -$114.3M | -$83.4M | -$20.6M | -$10.9M | |
| Diluted EPS | -$185.58 | -$20.99 | -$7.93 | -$7.29 | -$2.95 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $326.5M | $181.1M | $183.8M | |
| Total Assets | -- | -- | $455.5M | $265.3M | $269.4M | |
| Current Liabilities | -- | -- | $92.1M | $100.5M | $137.7M | |
| Total Liabilities | -- | -- | $119.4M | $129.6M | $206.5M | |
| Total Equity | -- | -- | $336.1M | $135.7M | $62.9M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$117.6M | -$60.7M | -$21.2M | -$6.8M | $31.4M | |
| Cash From Investing | -$172M | $66M | $14.1M | $260K | $6.2M | |
| Cash From Financing | -$2.6M | -$2.6M | $43.8M | -$132K | -$260K | |
| Free Cash Flow | -$148.1M | -$70.1M | -$24.3M | -$8.3M | $31.1M | |
BKKT
Sector
Market Cap
$62.3M
$603.7M
Price % of 52-Week High
25.61%
84.45%
Dividend Yield
0%
2.05%
Shareholder Yield
-28.84%
3.98%
1-Year Price Total Return
-4.32%
9.07%
Beta (5-Year)
--
0.555
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$9.28
200-day SMA
Sell
Level
$15.99
Bollinger Bands (100)
Sell
Level
9.8 - 25.26
Chaikin Money Flow
Sell
Level
-85.4M
20-day SMA
Buy
Level
$8.82
Relative Strength Index (RSI14)
Sell
Level
48.55
ADX Line
Buy
Level
9.7
Williams %R
Neutral
Level
-23.2628
50-day SMA
Sell
Level
$10.96
MACD (12, 26)
Sell
Level
-0.46
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
95.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.4581)
Buy
CA Score
(Annual)
Level (1.6711)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (4.2575)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bakkt Holdings Inc operates technology that connects the digital economy by offering a platform for crypto and redeeming loyalty points. Its institutional-grade technology platform provides a custody solution that caters to more experienced market participants to store crypto and provides consumers, businesses, and institutions with the ability to buy, sell, and store crypto in a simple, intuitive digital experience accessed via application programming interfaces (APIs) or embedded web experience and Loyalty offers a full spectrum of content that clients can make available to its customers when redeeming loyalty currencies. It generates revenue in the form of Subscription and service and Transaction revenue.
Stock Forecast FAQ
In the current month, BKKT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BKKT average analyst price target in the past 3 months is --.
-
Where Will Bakkt Holdings Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bakkt Holdings share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Bakkt Holdings?
Analysts are divided on their view about Bakkt Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bakkt Holdings is a Sell and believe this share price will drop from its current level to --.
-
What Is Bakkt Holdings's Price Target?
The price target for Bakkt Holdings over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is BKKT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bakkt Holdings is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of BKKT?
You can purchase shares of Bakkt Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bakkt Holdings shares.
-
What Is The Bakkt Holdings Share Price Today?
Bakkt Holdings was last trading at $9.25 per share. This represents the most recent stock quote for Bakkt Holdings. Yesterday, Bakkt Holdings closed at $9.53 per share.
-
How To Buy Bakkt Holdings Stock Online?
In order to purchase Bakkt Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 5.48% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.82% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 3.3% over the past day.
